NANALYSIS SCIENTI

Record Revenue and Positive EBITDA CALGARY, AB , Aug. 28, 2024 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines and MRI technology for industrial and research applications announces second quarter results for the period ending on June 30, 2024, achieving 65% year-over-year revenue growth to $11.5 million in Q2. Chief Executive Officer Sean Krakiwsky and Chief Financial Officer Randall McRae will host a conference call at 5 P.M. » Mehr auf prnewswire.com

Hosting Call at 5:00 pm ET on Wednesday, August 28th European Q&A Session on Thursday August 29th at 8:30am ET CALGARY, AB , Aug. 14, 2024 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines and MRI technology for industrial and research applications announces that on Wednesday, August 28th, 2024, the Company will put out a press release and Chief Executive Officer Sean Krakiwsky and Chief Financial Officer Randall McRae will host a conference call at 5:00 P.M. Eastern Time to discuss the results for the quarter ended June 30, 2024. » Mehr auf prnewswire.com

CALGARY, AB , June 28, 2024 /PRNewswire/ - Nanalysis Scientific Corp. ("Nanalysis" or the "Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), is pleased ‎to report that all proposed resolutions were approved at the Company's Annual General ‎and Special Meeting of shareholders held on June 26, 2024 (the "Meeting"). The number ‎of directors was set at 6 and all director nominees, as listed in the Management ‎Information Circular dated May 28, 2024, were elected as ‎directors of the Company at the Meeting to serve for a one-year term and hold office until ‎the next annual meeting of shareholders. » Mehr auf prnewswire.com